Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Psychiatry Reports
Erschienen in: Current Psychiatry Reports 1/2010

01.02.2010

Neuroinflammation and Cognitive Aging

verfasst von: Raymond L. Ownby

Erschienen in: Current Psychiatry Reports | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Cognitive aging describes the changes in mental abilities that occur with increasing age. Although experts disagree on the core underlying processes involved, one factor that links many factors associated with cognitive aging is neuroinflammation. Markers of inflammation are associated directly with deficits in cognitive function and with diseases that are risk factors for cognitive decline. Neuroinflammation is also associated with depression and may account for the complex interaction of depression and cognition in older adults. Interventions that reduce inflammation may improve cognition. Understanding how neuroinflammation affects cognition may provide directions for useful interventions to prevent or treat cognitive decline in older adults.
Literatur
1.
Park DC: The basic mechanisms accounting for age-related decline in cognitive function. In Cognitive Aging: A Primer. Edited by Park D, Schwarz N. Philadelphia: Taylor & Francis; 2000:3–21.
2.
Cattell RB: Theory of fluid and crystallized intelligence: a critical experiment. J Educ Psychol 1963, 54:1–22.CrossRef
3.
•• Grady CL: Cognitive neuroscience of aging. Ann N Y Acad Sci 2008, 1124:127–144. Grady provides an excellent review of the current status of research on cognitive aging.CrossRefPubMed
4.
Salthouse TA, Pink JE: Why is working memory related to fluid intelligence? Psychon Bull Rev 2008, 15:364–371.CrossRefPubMed
5.
•• Lindenberger U, Ghisletta P: Cognitive and sensory declines in old age: gauging the evidence for a common cause. Psychol Aging 2009, 24:1–16. This article provides a useful review of current thinking about possible links between changes in both mental and sensory status with increasing age.CrossRefPubMed
6.
Drachman DA: Aging of the brain, entropy, and Alzheimer disease. Neurology 2006, 67:1340–1352.CrossRefPubMed
7.
Yirmiya R, Pollak Y, Morag M, et al.: Illness, cytokines, and depression. Ann N Y Acad Sci 2000, 917:478–487.PubMedCrossRef
8.
Krabbe KS, Reichenberg A, Yirmiya R, et al.: Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 2005, 19:453–460.CrossRefPubMed
9.
Capuron L, Ravaud A, Miller AH, Dantzer R: Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav Immun 2004, 18:205–213.CrossRefPubMed
10.
Reichenberg A, Yirmiya R, Schuld A, et al.: Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001, 58:445–452.CrossRefPubMed
11.
Lau DC, Dhillon B, Yan H, et al.: Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 2005, 288:H2031–H2041.CrossRefPubMed
12.
Gomez CR, Boehmer ED, Kovacs EJ: The aging innate immune system. Curr Opin Immunol 2005, 17:457–462.CrossRefPubMed
13.
Hawkley LC, Cacioppo JT: Stress and the aging immune system. Brain Behav Immun 2004, 18:114–119.CrossRefPubMed
14.
Arimoto T, Choi DY, Lu X, et al.: Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol Aging 2007, 28:894–906.CrossRef
15.
Kuo HK, Yen CJ, Chang CH, et al.: Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005, 4:371–380.CrossRefPubMed
16.
•• Gimeno D, Kivimaki M, Brunner EJ, et al.: Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med 2009, 39:413–423. This article definitively links CRP and IL-6 with depression in a well-known longitudinal study.CrossRefPubMed
17.
Stampfer MJ: Cardiovascular disease and Alzheimer’s disease: common links. J Intern Med 2006, 260:211–223.CrossRefPubMed
18.
Helzner EP, Luchsinger JA, Scarmeas N, et al.: Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 2009, 66:343–348.CrossRefPubMed
19.
Li G, Cherrier MM, Tsuang DW, et al.: Salivary cortisol and memory function in human aging. Neurobiol Aging 2006, 27:1705–1714.CrossRefPubMed
20.
Lupien SJ, Lepage M: Stress, memory, and the hippocampus: can’t live with it, can’t live without it. Behav Brain Res 2001, 127:137–158.CrossRefPubMed
21.
Goshen I, Yirmiya R: Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009, 30:30–45.CrossRefPubMed
22.
Fried LP, Tangen CM, Walston J, et al.: Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:M146–M156.PubMed
23.
Bergman H, Ferrucci L, Guralnik J, et al.: Frailty: an emerging research and clinical paradigm issues and controversies. J Gerontol A Biol Sci Med Sci 2007, 62:731–737.PubMed
24.
Barzilay JI, Blaum C, Moore T, et al.: Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. Arch Intern Med 2007, 167:635–641.CrossRefPubMed
25.
Buchman AS, Schneider JA, Leurgans S, Bennett DA: Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology 2008, 71:499–504.CrossRefPubMed
26.
Hunter RL, Cheng B, Choi DY, et al.: Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice. J Neurosci Res 2009, 87:1913–1921.CrossRefPubMed
27.
Long-Smith CM, Sullivan AM, Nolan YM: The influence of microglia on the pathogenesis of Parkinson’s disease. Prog Neurobiol 2009 Aug 15 (Epub ahead of print).
28.
Backman L, Nyberg L, Lindenberger U, et al.: The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neurosci Biobehav Rev 2006, 30:791–807.CrossRefPubMed
29.
Beydoun MA, Beydoun HA, Wang Y: Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008, 9:204–218.CrossRefPubMed
30.
Sweat V, Starr V, Bruehl H, et al.: C-reactive protein is linked to lower cognitive performance in overweight and obese women. Inflammation 2008, 31:198–207.CrossRefPubMed
31.
Penninx BW, Nicklas BJ, Newman AB, et al.: Metabolic syndrome and physical decline in older persons: results from the Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci 2009, 64:96–102.PubMed
32.
Vogelzangs N, Beekman AT, Dik MG, et al.: Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry 2009, 17:716–721.CrossRefPubMed
33.
Yaffe K, Weston AL, Blackwell T, Krueger KA: The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 2009, 66:324–328.CrossRefPubMed
34.
Craft S: The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 2009, 66:300–305.CrossRefPubMed
35.
Roriz-Filho S, Sa-Roriz TM, Rosset I, et al.: (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792:432–443.
36.
Dik MG, Jonker C, Comijs HC, et al.: Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 2007, 30:2655–2660.CrossRefPubMed
37.
Segura B, Jurado MA, Freixenet N, et al.: Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 2009, 462:49–53.CrossRefPubMed
38.
Capuron L, Su S, Miller AH, et al.: Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry 2008, 64:896–900.CrossRefPubMed
39.
Ladwig KH, Marten-Mittag B, Lowel H, et al.: C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984–1998. Eur Heart J 2005, 26:2537–2542.CrossRefPubMed
40.
Martinowich K, Manji H, Lu B: New insights into BDNF function in depression and anxiety. Nat Neurosci 2007, 10:1089–1093.CrossRefPubMed
41.
Arentoft A, Sweat V, Starr V, et al.: Plasma BDNF is reduced among middle-aged and elderly women with impaired insulin function: evidence of a compensatory mechanism. Brain Cogn 2009, 71:147–152.CrossRefPubMed
42.
Li G, Peskind ER, Millard SP, et al.: Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 2009, 4:e5424.CrossRefPubMed
43.
Gomez-Pinilla F, Vaynman S, Ying Z: Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur J Neurosci 2008, 28:2278–2287.CrossRefPubMed
44.
Venneri A, Lane R: Effects of cholinesterase inhibition on brain white matter volume in Alzheimer’s disease. Neuroreport 2009, 20:285–288.CrossRefPubMed
45.
Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007, 117:289–296.CrossRefPubMed
46.
ADAPT Research Group: Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007, 68:1800–1808.CrossRefPubMed
47.
Vlad SC, Miller DR, Kowall NW, Felson DT: Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 2008, 70:1672–1677.CrossRefPubMed
48.
Szekely CA, Breitner JC, Fitzpatrick AL, et al.: NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology 2008, 70:17–24.CrossRefPubMed
49.
Kris-Etherton PM, Harris WS, Appel LJ; Nutrition Committee: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2003, 23:e20–e30. (Published erratum appears in Arterioscler Thromb Vasc Biol 2003, 23:e31.)CrossRefPubMed
50.
Morris MC, Evans DA, Bienias JL, et al.: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003, 60:940–946.CrossRefPubMed
51.
Fotuhi M, Mohassel P, Yaffe K: Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 2009, 5:140–152.CrossRefPubMed
52.
Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, et al.: Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind trial. Arch Neurol 2006, 63:1402–1408.CrossRefPubMed
53.
Wolozin B, Wang SW, Li NC, et al.: Simvastatin is associated with a reduced incidence of dementia and Parkinson’s disease. BMC Med 2007, 5:20.CrossRefPubMed
54.
Li G, Larson EB, Sonnen JA, et al.: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 2007, 69:878–885.CrossRefPubMed
55.
Solomon A, Kareholt I, Ngandu T, et al.: Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging 2009, 30:1006–1009.CrossRefPubMed
56.
Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154–1162.CrossRefPubMed
57.
Ownby RL, Loewenstein DA, Kumar M: Anti-inflammatory effects mediate the relation between physical activity and mood in older adults. Paper presented at the Annual Meeting of the International Society of Psychoneuroendocrinology. San Francisco, CA; August 2009.
58.
•• Cotman CW, Berchtold NC, Christie LA: Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci 2007, 30:464–472. This is an excellent review of the possible links between exercise and cognitive function by way of inflammatory processes.CrossRefPubMed
59.
Colcombe S, Kramer AF: Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci 2003, 14:125–130.CrossRefPubMed
60.
Willis SL, Tennstedt SL, Marsiske M, et al.: Long-term effects of cognitive training on everyday functional outcomes in older adults. JAMA 2006, 296:2805–2814.CrossRefPubMed
61.
•• Jaeggi SM, Buschkuehl M, Jonides J, Perrig WJ: Improving fluid intelligence with training on working memory. Proc Natl Acad Sci U S A 2008, 105:6829–6833. This article reports the exciting finding that training in one cognitive domain may have positive effects in another.CrossRefPubMed
62.
•• McNab F, Varrone A, Farde L, et al.: Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science 2009, 323:800–802. This study shows that working memory training may have effects on D 1 -receptor density in areas relevant to working memory function, providing a possible mechanism for the observation by Jaeggi et al. [61••] that working memory training may improve other aspects of cognitive function.CrossRefPubMed
63.
Buschkuehl M, Jaeggi SM, Hutchison S, et al.: Impact of working memory training on memory performance in old-old adults. Psychol Aging 2008, 23:743–753.CrossRefPubMed
Metadaten
Titel
Neuroinflammation and Cognitive Aging
verfasst von
Raymond L. Ownby
Publikationsdatum
01.02.2010
Verlag
Current Science Inc.
Erschienen in
Current Psychiatry Reports / Ausgabe 1/2010
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-009-0082-1

Weitere Artikel der Ausgabe 1/2010

Current Psychiatry Reports 1/2010 Zur Ausgabe

OriginalPaper

Effectiveness of Different Psychotherapy Approaches in the Treatment of Borderline Personality Disorder

OriginalPaper

How Late-Life Depression Affects Cognition: Neural Mechanisms

OriginalPaper

Sensitivity to Antipsychotic Drugs in Older Adults

OriginalPaper

Narcissistic Personality Disorder: A Current Review

OriginalPaper

Neuroimaging of Psychopathy and Antisocial Behavior: A Targeted Review

OriginalPaper

The Relationship Between Sleep and Anxiety in Older Adults

Neu im Fachgebiet Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise